Guillain-Barré syndrome after coronavirus disease 2019 vaccine: A temporal association.
Gustavo Figueiredo da SilvaCaroline Figueiredo da SilvaRaddib Eduardo Noleto da Nobrega OliveiraFabiana RomanciniRafael Marques MendesAmanda LocksMaria Francisca Moro LongoCarla Heloisa Cabral MoroAlexandre Luiz LongoVera Lucia BraatzPublished in: Clinical & experimental neuroimmunology (2021)
In the absence of other causes, the diagnosis of GBS was made, with evidence of a clear temporal association with COVID-19 vaccine. However, a cautious position is important when assigning a particular side-effect directly to a vaccine. It is important to emphasize that it is a temporal association only and the benefits of COVID-19 vaccination continue to outweigh the possible consequences.